File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Precision surgery for hepatocellular carcinoma

TitlePrecision surgery for hepatocellular carcinoma
Authors
Issue Date21-Feb-2025
PublisherElsevier
Citation
The Lancet Gastroenterology & Hepatology, 2025, v. 10, n. 4, p. 350-368 How to Cite?
Abstract

Hepatocellular carcinoma arises in the setting of cirrhosis in most cases, requiring multidisciplinary input to define resectability. In this regard, more precise surgical management considers patient factors and anatomical states, including resection margins, tumour biology, and perioperative therapy. Together with advances in surgical techniques, this integrated approach has resulted in considerable improvements in patient morbidity and oncological outcomes. Despite this, recurrence rates in hepatocellular carcinoma remain high. As the systemic treatment landscape in hepatocellular carcinoma continues to evolve and locoregional options are increasingly used, we review current and future opportunities to individualise the surgical management of patients with hepatocellular carcinoma.


Persistent Identifierhttp://hdl.handle.net/10722/354940
ISSN
2023 Impact Factor: 30.9
2023 SCImago Journal Rankings: 8.957

 

DC FieldValueLanguage
dc.contributor.authorMagyar, Christian Tibor Josef-
dc.contributor.authorRajendran, Luckshi-
dc.contributor.authorLi, Zhihao-
dc.contributor.authorBanz, Vanessa-
dc.contributor.authorVogel, Arndt-
dc.contributor.authorO'Kane, Grainne Mary-
dc.contributor.authorChan, Albert Chi-Yan-
dc.contributor.authorSapisochin Gonzalo-
dc.date.accessioned2025-03-18T00:35:29Z-
dc.date.available2025-03-18T00:35:29Z-
dc.date.issued2025-02-21-
dc.identifier.citationThe Lancet Gastroenterology & Hepatology, 2025, v. 10, n. 4, p. 350-368-
dc.identifier.issn2468-1253-
dc.identifier.urihttp://hdl.handle.net/10722/354940-
dc.description.abstract<p>Hepatocellular carcinoma arises in the setting of cirrhosis in most cases, requiring multidisciplinary input to define resectability. In this regard, more precise surgical management considers patient factors and anatomical states, including resection margins, tumour biology, and perioperative therapy. Together with advances in surgical techniques, this integrated approach has resulted in considerable improvements in patient morbidity and oncological outcomes. Despite this, recurrence rates in hepatocellular carcinoma remain high. As the systemic treatment landscape in hepatocellular carcinoma continues to evolve and locoregional options are increasingly used, we review current and future opportunities to individualise the surgical management of patients with hepatocellular carcinoma.<br></p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofThe Lancet Gastroenterology & Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titlePrecision surgery for hepatocellular carcinoma-
dc.typeArticle-
dc.identifier.doi10.1016/S2468-1253(24)00434-5-
dc.identifier.volume10-
dc.identifier.issue4-
dc.identifier.spage350-
dc.identifier.epage368-
dc.identifier.eissn2468-1253-
dc.identifier.issnl2468-1156-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats